Hirotaka Takahashi Selected Research

Hirotaka Takahashi Research Topics

Disease

7	Infections 01/2016 - 02/2003
5	Paralysis (Palsy) 12/2013 - 02/2003
4	Neoplasms (Cancer) 01/2019 - 05/2009
4	Facial Paralysis (Facial Palsy) 12/2013 - 03/2005
3	Inflammation (Inflammations) 11/2019 - 02/2016
3	Bell Palsy (Bell's Palsy) 12/2013 - 11/2003
2	Allergic Rhinitis 12/2016 - 02/2016
2	Otitis Media with Effusion 04/2014 - 02/2011
1	Arthritis (Polyarthritis) 01/2019
1	Multiple Myeloma 01/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Dent Disease 01/2017
1	Familial Hypophosphatemia (Phosphate Diabetes) 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Leukemia 01/2017
1	Lung Diseases (Lung Disease) 01/2017
1	Hypercalciuria 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2017
1	T-Cell Leukemia (Leukemia, T Cell) 01/2017
1	Genetic Translocation (Chromosomal Translocation) 01/2017
1	Proteinuria 01/2017
1	Seasonal Allergic Rhinitis (Hay Fever) 12/2016
1	Dengue (Dengue Fever) 01/2016
1	RNA Virus Infections 03/2015
1	Virus Diseases (Viral Diseases) 03/2015
1	Human Influenza (Influenza) 03/2015
1	Vesicular Stomatitis 03/2015
1	Retinoblastoma (Glioblastoma, Retinal) 01/2014
1	Anosmia 04/2013
1	Diabetes Mellitus 04/2011
1	Sinusitis 04/2011
1	Sensorineural Hearing Loss 02/2011
1	Ototoxicity 02/2011
1	Long Term Adverse Effects 02/2011
1	Otitis Externa 02/2011
1	Nasopharyngeal Carcinoma 02/2011
1	Otitis Media 02/2011
1	Zoster Sine Herpete 10/2008
1	Herpesviridae Infections (Herpesvirus Infection) 02/2003
1	Demyelinating Diseases (Demyelinating Disease) 11/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2014
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2013 - 01/2010
2	Phosphates (Orthophosphate)IBA 04/2013 - 02/2003
2	HydrogelsIBA 04/2013 - 01/2010
2	Prednisolone (Predate)FDA LinkGeneric 10/2008 - 11/2003
2	Acyclovir (Aciclovir)FDA LinkGeneric 11/2003 - 02/2003
1	CytokinesIBA 11/2019
1	UbiquitinIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	PolyubiquitinIBA 01/2019
1	Deubiquitinating Enzyme CYLDIBA 01/2019
1	Deubiquitinating EnzymesIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019
1	N,N'- bis- (2,4- dimethyl- phenyl)- ethane- 1,2- diamineIBA 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Proteasome InhibitorsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Hexosaminidases (Hexosaminidase)IBA 01/2017
1	tax Gene Products (tax Gene Product)IBA 01/2017
1	CreatinineIBA 01/2017
1	ChlorophyllIBA 12/2016
1	Type A Botulinum Toxins (Botox)FDA Link 02/2016
1	OvalbuminIBA 02/2016
1	Antiviral Agents (Antivirals)IBA 01/2016
1	InterferonsIBA 01/2016
1	VaccinesIBA 01/2016
1	Dual Specificity Phosphatase 1IBA 03/2015
1	Interferon Type IIBA 03/2015
1	Dual-Specificity PhosphatasesIBA 03/2015
1	NucleoproteinsIBA 09/2014
1	Viral DNAIBA 09/2014
1	PhosphoproteinsIBA 01/2014
1	EdaravoneIBA 12/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2013
1	Free Radical ScavengersIBA 12/2013
1	Skatole (3 Methylindole)IBA 04/2013
1	GelatinIBA 04/2013
1	Complementary DNA (cDNA)IBA 01/2013
1	Phosphatidate PhosphataseIBA 01/2013
1	MyogeninIBA 07/2012
1	Phospholipid Transfer ProteinsIBA 07/2012
1	Pathogen-Associated Molecular Pattern MoleculesIBA 07/2012
1	SteroidsIBA 04/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2011
1	Valacyclovir (Valtrex)FDA LinkGeneric 10/2008
1	Immunologic Factors (Immunomodulators)IBA 03/2005
1	Therapeutic UsesIBA 11/2003
1	BuffersIBA 02/2003
1	OsmiumIBA 11/2002

Therapy/Procedure

3	Therapeutics 01/2018 - 11/2003
1	Tympanoplasty 04/2014
1	Intravenous Infusions 04/2013
1	Intraperitoneal Injections 04/2013
1	Denervation 07/2012
1	Radiotherapy 02/2011
1	Otoscopes 02/2011
1	Palliative Care (Palliative Therapy) 05/2009